Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor

PLoS One. 2015 Aug 17;10(8):e0135998. doi: 10.1371/journal.pone.0135998. eCollection 2015.

Abstract

Atomistic descriptions of the μ-opioid receptor (μOR) noncovalently binding with two of its prototypical morphinan agonists, morphine (MOP) and hydromorphone (HMP), are investigated using molecular dynamics (MD) simulations. Subtle differences between the binding modes and hydration properties of MOP and HMP emerge from the calculations. Alchemical free energy perturbation calculations show qualitative agreement with in vitro experiments performed in this work: indeed, the binding free energy difference between MOP and HMP computed by forward and backward alchemical transformation is 1.2±1.1 and 0.8±0.8 kcal/mol, respectively, to be compared with 0.4±0.3 kcal/mol from experiment. Comparison with an MD simulation of μOR covalently bound with the antagonist β-funaltrexamine hints to agonist-induced conformational changes associated with an early event of the receptor's activation: a shift of the transmembrane helix 6 relative to the transmembrane helix 3 and a consequent loss of the key R165-T279 interhelical hydrogen bond. This finding is consistent with a previous proposal suggesting that the R165-T279 hydrogen bond between these two helices indicates an inactive receptor conformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arrestins / metabolism
  • Cyclic AMP / metabolism
  • Hydromorphone / metabolism*
  • Models, Theoretical
  • Molecular Dynamics Simulation
  • Morphine / metabolism
  • Protein Binding
  • Receptors, Opioid, mu / metabolism*
  • Thermodynamics

Substances

  • Arrestins
  • Receptors, Opioid, mu
  • Morphine
  • Cyclic AMP
  • Hydromorphone

Grants and funding

This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013, http://ec.europa.eu/research/fp7) under Grant Agreement N. 604102 (the Human Brain Project) to P. Carloni. The in vitro data were provided by Grünenthal GmbH through research collaboration without additional financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grünenthal GmbH provided support in the form of salaries for authors [AK, IS, MW and TK] but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.